Findlay Park Partners LLP Buys 792,942 Shares of Becton, Dickinson and Company (BDX)

Findlay Park Partners LLP raised its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 85.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,725,000 shares of the medical instruments supplier’s stock after acquiring an additional 792,942 shares during the period. Becton, Dickinson and makes up approximately 3.4% of Findlay Park Partners LLP’s holdings, making the stock its 8th biggest position. Findlay Park Partners LLP owned approximately 0.81% of Becton, Dickinson and worth $336,565,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of BDX. Waldron LP bought a new position in Becton, Dickinson and during the 1st quarter valued at about $383,000. British Columbia Investment Management Corp lifted its stake in Becton, Dickinson and by 8.3% during the 1st quarter. British Columbia Investment Management Corp now owns 118,540 shares of the medical instruments supplier’s stock valued at $21,745,000 after acquiring an additional 9,084 shares during the period. Gabelli Funds LLC lifted its stake in Becton, Dickinson and by 10.4% during the 1st quarter. Gabelli Funds LLC now owns 103,700 shares of the medical instruments supplier’s stock valued at $19,023,000 after acquiring an additional 9,800 shares during the period. Goelzer Investment Management Inc. bought a new position in Becton, Dickinson and during the 1st quarter valued at about $237,000. Finally, Thomaspartners Inc. lifted its stake in Becton, Dickinson and by 6.9% during the 1st quarter. Thomaspartners Inc. now owns 1,134,326 shares of the medical instruments supplier’s stock valued at $208,081,000 after acquiring an additional 73,683 shares during the period. Institutional investors and hedge funds own 87.12% of the company’s stock.

In related news, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen Sichak sold 11,787 shares of Becton, Dickinson and stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $200.46, for a total value of $2,362,822.02. Following the sale, the insider now directly owns 14,038 shares of the company’s stock, valued at approximately $2,814,057.48. The disclosure for this sale can be found here. Insiders have sold 75,904 shares of company stock valued at $15,242,688 in the last ninety days. Corporate insiders own 1.40% of the company’s stock.

BDX has been the topic of several research analyst reports. Raymond James Financial, Inc. upgraded shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $210.00 to $180.00 in a research note on Friday, June 30th. Cowen and Company restated an “outperform” rating and set a $230.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Monday, July 10th. BidaskClub upgraded shares of Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price on the stock in a research note on Monday, July 17th. Finally, Bank of America Corporation restated a “buy” rating and set a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $200.93.

WARNING: “Findlay Park Partners LLP Buys 792,942 Shares of Becton, Dickinson and Company (BDX)” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://ledgergazette.com/2017/10/11/findlay-park-partners-llp-buys-792942-shares-of-becton-dickinson-and-company-bdx.html.

Shares of Becton, Dickinson and Company (NYSE BDX) opened at 196.29 on Wednesday. Becton, Dickinson and Company has a 52-week low of $161.29 and a 52-week high of $206.63. The stock’s 50 day moving average is $197.12 and its 200 day moving average is $192.80. The stock has a market cap of $44.67 billion, a price-to-earnings ratio of 56.85 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. During the same quarter in the previous year, the company posted $2.35 earnings per share. The company’s revenue was down 5.1% compared to the same quarter last year. On average, equities analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 8th were issued a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is 83.43%.

A number of other institutional investors and hedge funds also recently bought and sold shares of BDX. Waldron LP bought a new position in Becton, Dickinson and during the 1st quarter valued at about $383,000. British Columbia Investment Management Corp lifted its stake in Becton, Dickinson and by 8.3% during the 1st quarter. British Columbia Investment Management Corp now owns 118,540 shares of the medical instruments supplier’s stock valued at $21,745,000 after acquiring an additional 9,084 shares during the period. Gabelli Funds LLC lifted its stake in Becton, Dickinson and by 10.4% during the 1st quarter. Gabelli Funds LLC now owns 103,700 shares of the medical instruments supplier’s stock valued at $19,023,000 after acquiring an additional 9,800 shares during the period. Goelzer Investment Management Inc. bought a new position in Becton, Dickinson and during the 1st quarter valued at about $237,000. Finally, Thomaspartners Inc. lifted its stake in Becton, Dickinson and by 6.9% during the 1st quarter. Thomaspartners Inc. now owns 1,134,326 shares of the medical instruments supplier’s stock valued at $208,081,000 after acquiring an additional 73,683 shares during the period. Institutional investors and hedge funds own 87.12% of the company’s stock.

In related news, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen Sichak sold 11,787 shares of Becton, Dickinson and stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $200.46, for a total value of $2,362,822.02. Following the sale, the insider now directly owns 14,038 shares of the company’s stock, valued at approximately $2,814,057.48. The disclosure for this sale can be found here. Insiders have sold 75,904 shares of company stock valued at $15,242,688 in the last ninety days. Corporate insiders own 1.40% of the company’s stock.

BDX has been the topic of several research analyst reports. Raymond James Financial, Inc. upgraded shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $210.00 to $180.00 in a research note on Friday, June 30th. Cowen and Company restated an “outperform” rating and set a $230.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Monday, July 10th. BidaskClub upgraded shares of Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price on the stock in a research note on Monday, July 17th. Finally, Bank of America Corporation restated a “buy” rating and set a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $200.93.

WARNING: “Findlay Park Partners LLP Buys 792,942 Shares of Becton, Dickinson and Company (BDX)” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://ledgergazette.com/2017/10/11/findlay-park-partners-llp-buys-792942-shares-of-becton-dickinson-and-company-bdx.html.

Shares of Becton, Dickinson and Company (NYSE BDX) opened at 196.29 on Wednesday. Becton, Dickinson and Company has a 52-week low of $161.29 and a 52-week high of $206.63. The stock’s 50 day moving average is $197.12 and its 200 day moving average is $192.80. The stock has a market cap of $44.67 billion, a price-to-earnings ratio of 56.85 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. During the same quarter in the previous year, the company posted $2.35 earnings per share. The company’s revenue was down 5.1% compared to the same quarter last year. On average, equities analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 8th were issued a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is 83.43%.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply